Sandbox vidit3: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:


! Dosage
! Dosage
|-
----
! Direct FXa inhibitors


|-
|-
Line 27: Line 32:
|-
|-


| Bivalirudin
| [[Bivalirudin]]


| Bolus: None <br> Continuous infusion: <br>
| Bolus: None <br> Continuous infusion: <br>
Line 37: Line 42:
|-
|-
----
----
| Danaparoid
 
! Indirect FXa inhibitors
 
|-
 
| [[Danaparoid]]


| Bolus: <br>
| Bolus: <br>

Revision as of 16:04, 2 January 2014



Agent Dosage
Direct FXa inhibitors
Argatroban Bolus: None
Continuous infusion:
♦ Normal organ function - 2 μg/kg per minute
♦ Liver dysfunction (total serum bilirubin 1.5 mg/dL), heart failure, postcardiac surgery, anasarca - 0.5-1.2 μg/kg per minute
Lepirudin Bolus:0.2 mg/kg (only for life- or limb-threatening thrombosis)
Continuous infusion:
♦ Cr < 1.0 mg/dL - 0.10 mg/kg per hour
♦ Cr 1.0-1.6 mg/dL - 0.05 mg/kg per hour
♦ Cr 1.6-4.5 mg/dL - 0.01 mg/kg per hour
♦ Cr > 4.5 mg/dL - 0.005 mg/kg per hour
Bivalirudin Bolus: None
Continuous infusion:
♦ Normal organ function - 0.15 mg/kg per hour
♦ Renal or hepatic dysfunction - dose reduction may be appropriate


Indirect FXa inhibitors
Danaparoid Bolus:
♦ < 60 kg - 1500 U
♦ 60-75 kg - 2250 U
♦ 75-90 kg - 3000 U
♦ > 90 kg - 3750 U

Accelerated initial infusion: 400 U/hour X 4 hours, then 300 U/hour X 4 hours
Maintenance infusion:

♦ Normal renal function - 200 U/hour
♦ Renal insufficiency - 150 U/hour